The Latest

  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Pfizer CMO Dr. Aida Habtezion

    Pfizer's CMO shares how her experiences transforming the company's R&D culture and improving health equity

  • Image attribution tooltip
    Dan Kitwood via Getty Images

    5 trends shaping clinical trial regulations in 2022

    As agencies respond to innovations in pharma, notable shifts in 2022 are on the way.

  • Image attribution tooltip
    Space Frontiers via Getty Images
    Profile

    Vaxxinity looks to pioneer the next revolution in pharma

    With a one-of-a-kind platform and novel candidates for major indications, Vaxxinity wants to disrupt the industry’s paradigm of success. 

  • Image attribution tooltip
    Jack Taylor via Getty Images

    Pharma M&A stagnated in 2021 — here's what could help it rebound

    There are plenty of reasons pharma could get its M&A groove back in 2022.

  • Image attribution tooltip
    Permission granted by Copyright: <a href='https://www.123rf.com/profile_ileezhun'>ileezhun</a>

    Biote CEO breaks down barriers in women's health

    Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.

  • Image attribution tooltip
    Justin Sullivan/ via Getty Images
    Q&A

    How the executive VP of HR at Incyte is tackling pharma's hiring woes

    In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.

  • Image attribution tooltip
    [photo]. Retrieved from Ovid Therapeutics.
    Q&A

    Ovid's CEO shares his vision for rare disease developments

    Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

  • Image attribution tooltip
    Justin Sullivan via Getty Images

    Australian firefighters raise funds for ALS research

    Funding for rare disease clinical trials can be a challenge, but in Australia, firefighters gear up to raise money for ALS. 

  • Image attribution tooltip
    [photo]. Retrieved from Google image.

    Rare disease innovation in 2022

    More companies are targeting gene therapies for rare disease treatments.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice

    Welcome to the new PharmaVoice

    A similar mission, a new format, and our plans for PharmaVoice's next chapter.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week Podcast: Astrid DeFries-Lansing

    Astrid DeFries-Lansing, EVP, Executive Creative Director, GSW, powered by Syneos Health, who believes creativity is an attitude not simply a skill set, speaks to her approach in developing campaigns that speak to human truths, are beautiful, and resonate with audiences.

  • Image attribution tooltip
    Retrieved from Google image.
    Opinion

    Pharma execs reveal the industry's most pressing issues

    Several market factors — including COVID — are driving changes and trends in the industry.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice

    PharmaVoice 100 Nomination Form

    Recognition for the most inspiring people in the life-sciences industry, as determined by our readers.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week Podcast: Marie Lamont

    Marie Lamont, General Manager of Inteliquet, shares her insights on why clinical trials as a care option is so important, how to employ creative tension to build high-performing teams, and how to thoughtfully and purposefully build a network can lead to career success.

  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week Podcast: Barbara Krebs-Pohl, Ph.D.

    Dr. Barbara Krebs-Pohl, SVP, Head of Global BD&L and Alliance Management of MorphoSys, shares her extraordinary scientific journey from academia to business, including in-licensing and M&A, all with the goal of cures in mind for cancer.